Level of instruction: Intermediate
Intended Audience: Clinical laboratory technologists and technicians, and other health care personnel who have an interest in this subject matter. This course is also appropriate for clinical laboratory science students and pathology residents.
Author Information: Kevin F. Foley, PhD, DABCC, MT, SC is the Northwest chemistry, toxicology, immunology and POC director for Kaiser Permanente. He also teaches pharmacology, clinical chemistry, immunology and medicinal chemistry at Oregon Health Sciences University. Dr. Foley earned his PhD in clinical pharmacology and toxicology at East Carolina School of Medicine in North Carolina. His research areas include cardiovascular risk and inflammation markers as well as the neuropharmacology of amphetamine-like compounds. He is a frequent contributor to several clinical laboratory publications and is active in the American Association of Clinical Chemistry.
Reviewer information: John Contois, PhD, DABCC, FACB is the Manager of Research and Development for Maine Standards Company. He holds a MS and PhD in Nutritional Sciences from the University of Connecticut and an MBA from the University of North Carolina and is certified as a Diplomate with the American Board of Clinical Chemistry and a Fellow with the National Academy of Clinical Biochemistry. Dr. Contois has a patent pending on a method for measuring the number of atherogenic low density lipoprotein particles in blood.